Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Arizona

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Phoenix Arizona 85013

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

UPDATED

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

UPDATED

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

View More ▼

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Tucson Arizona 85718

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Arkansas

UPDATED

Fayetteville Arkansas 72703

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

Jonesboro Arkansas 72401

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Little Rock Arkansas 72211

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

Springdale Arkansas 72764

A Phase 3 clinical study for patients with Alzheimer's Disease

California

UPDATED

Senior Clinical Trials, Inc.
Laguna Hills California 92653

Clinical trial for Engage + Emerge

UPDATED

Renew Behavioral Health
Long Beach California 90807

Clinical trial for Engage + Emerge

UPDATED

Renew Behavioral Health, Inc.
Long Beach California 90807

Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

UPDATED

Excell Research, Inc
Oceanside California 92056

Clinical trial for Engage + Emerge

UPDATED

Anderson Clinical Research
Redlands California 92374

Clinical trial for Engage + Emerge

UPDATED

Syrentis Clinical Research
Santa Ana California 92705

Clinical trial for Engage + Emerge

UPDATED

California Neuroscience Research
Sherman Oaks California 91403

Clinical trial for Engage + Emerge

View More ▼

UPDATED

Anaheim California 92805

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Anaheim California 92805

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

UPDATED

Bellflower California 90706

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

Carlsbad California 92011

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Costa Mesa California 92626

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Fresno California 93710

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Fullerton California 92835

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

UPDATED

Glendale California 91206

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

Irvine California 92607

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Laguna Hills California 92653

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

UPDATED

Long Beach California 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

UPDATED

Los Gatos California 95032

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

UPDATED

Newport Beach California 92658

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

UPDATED

Newport Beach California 92663

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Oceanside California 92056

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Oxnard California 93030

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Oxnard California 93030

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

Redlands California 92354

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

UPDATED

San Diego California 92103

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

UPDATED

San Diego California 92123

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

San Diego California 92103-6204

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

San Diego California 92103

A Phase 3 clinical study for patients with Alzheimer's Disease